JETEMA Co.,Ltd. Logo

JETEMA Co.,Ltd.

Develops and manufactures toxins, fillers, and threads for the aesthetic medicine market.

216080 | KO

Overview

Corporate Details

ISIN(s):
KR7216080002
LEI:
Country:
South Korea
Address:
강원도 원주시 지정면 조엄로 321, 원주시

Description

JETEMA Co., Ltd. is a research-driven biopharmaceutical company specializing in the development and manufacturing of innovative medicines and medical devices for the aesthetic medicine market. The company's core product portfolio includes botulinum toxins, hyaluronic acid-based dermal fillers, and lifting threads. With a strong focus on research and development, JETEMA aims to provide advanced solutions for anti-aging and aesthetic enhancement. The company's name is derived from the Latin word 'Zetéma', meaning 'research', reflecting its commitment to scientific innovation in creating products for a healthy and beautiful life.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-17 00:00
[기재정정]주식매수선택권부여에관한신고
Korean 21.8 KB
2025-12-17 00:00
[기재정정]주식매수선택권부여에관한신고
Korean 21.6 KB
2025-12-17 00:00
[기재정정]주식매수선택권부여에관한신고
Korean 21.8 KB
2025-08-27 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 26.5 KB
2025-08-14 00:00
반기보고서 (2025.06)
Korean 1.6 MB
2025-07-04 00:00
전환사채(해외전환사채포함)발행후만기전사채취득
Korean 11.8 KB
2025-06-27 00:00
증권발행결과(자율공시)
Korean 5.6 KB
2025-06-25 00:00
주요사항보고서(전환사채권발행결정)
Korean 70.8 KB
2025-05-15 00:00
분기보고서 (2025.03)
Korean 1.5 MB
2025-05-09 00:00
금전대여결정
Korean 19.3 KB
2025-04-30 00:00
소속부변경
Korean 3.6 KB
2025-04-28 00:00
기타경영사항(자율공시)
Korean 7.6 KB
2025-04-24 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.1 KB
2025-04-24 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 29.1 KB
2025-04-15 00:00
주식등의대량보유상황보고서(일반)
Korean 174.7 KB

Automate Your Workflow. Get a real-time feed of all JETEMA Co.,Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for JETEMA Co.,Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for JETEMA Co.,Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Acurx Pharmaceuticals, Inc. Logo
Clinical-stage biopharma developing a new class of antibiotics for priority pathogens.
United States of America
ACXP
Adaptimmune Therapeutics PLC Logo
Commercial-stage biopharma developing TCR T-cell therapies for solid tumors.
United States of America
ADAP
ADBIOTECH Co.,Ltd. Logo
Develops IgY-based immune antibodies as alternatives to vaccines and antibiotics.
South Korea
179530
ADC Therapeutics SA Logo
Commercial-stage biotech developing antibody-drug conjugates for cancer therapy.
United States of America
ADCT
Addex Therapeutics Ltd. Logo
Clinical-stage biopharma developing allosteric modulators for neurological disorders.
Switzerland
ADXN
ADIAL PHARMACEUTICALS, INC. Logo
A clinical-stage biopharma developing genetically targeted therapies for addiction.
United States of America
ADIL
Adicet Bio, Inc. Logo
Develops allogeneic gamma delta T cell therapies for cancer and autoimmune diseases.
United States of America
ACET
Adlai Nortye Ltd. Logo
A clinical-stage biopharma firm developing cancer immunotherapies and RAS-targeting drugs.
United States of America
ANL
ADMA BIOLOGICS, INC. Logo
Biopharmaceutical company that develops and manufactures plasma-derived biologics.
United States of America
ADMA
Adverum Biotechnologies, Inc. Logo
A clinical-stage company developing gene therapies for ocular diseases.
United States of America
ADVM

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.